Corneal inlay procedures are now undergoing FDA trials in the U.S. and are not available for wide use. Preliminary results show this to be an exciting new approach to the treatment of presbyopia.
While the promise of this technology is intriguing, as with all new things, we recommend a wait and see approach until more studies have been done on its safety, effectiveness, and longevity.
For patients who are not candidates for LASIK eye surgery, many alternatives exist. Visian ICL is another treatment option for those who cannot undergo LASIK. Learn more about Visian ICL here, and call Benjamin Eye Institute at to apply for your 24 month interest free financing!
